Multicenter, Open Label, Phase II Clinical Study of Gemcitabine, Capecitabine and Avastin in Pancreatic Cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2016
At a glance
- Drugs Bevacizumab (Primary) ; Capecitabine; Gemcitabine
- Indications Pancreatic cancer
- Focus Therapeutic Use
- 05 Mar 2012 Additional lead trial investigator (Renuka Iyer) identified as reported by ClinicalTrials.gov.
- 03 Feb 2010 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.
- 17 Dec 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.